亚洲国产一-亚洲国产系列一区二区三区-亚洲国产系列久久精品99人人-亚洲国产午夜精品乱码-国产在线精品99一卡2卡-国产在线黄色

托伐普坦

 
 
單價 面議對比
詢價 暫無
發(fā)貨 廣東深圳市付款后3天內(nèi)
品牌 深圳市思科達生物技術(shù)有限公司
過期 長期有效
更新 2015-02-02 15:07
 

深圳市思科達生物技術(shù)有限公司

企業(yè)會員第12年
資料未認證
保證金未繳納
詳細說明
 產(chǎn)品名稱: 托伐普坦雜質(zhì)ABCDE/Tolvaptan impurity ABCDE 

別名: 托伐普坦雜質(zhì)ABCDE 

裝量: 25mg,50mg 

價格: 詢價 

貯存: 冷藏 

1

托伐普坦雜質(zhì)A:Tolvaptan impurity A

規(guī)格:25mg,50mg,純度:大于99%,隨貨提供COA,氫譜,質(zhì)譜,液相等

2

托伐普坦雜質(zhì)B:Tolvaptan impurity B

規(guī)格:25mg,50mg,純度:大于99%,隨貨提供COA,氫譜,質(zhì)譜,液相等

3

托伐普坦雜質(zhì)C:Tolvaptan impurity C

規(guī)格:25mg,50mg,純度:大于99%,隨貨提供COA,氫譜,質(zhì)譜,液相等

4

托伐普坦雜質(zhì)D:Tolvaptan impurity D

規(guī)格:25mg,50mg,純度:大于99%,隨貨提供COA,氫譜,質(zhì)譜,液相等

5

托伐普坦雜質(zhì)E:Tolvaptan impurity E

規(guī)格:25mg,50mg,純度:大于99%,隨貨提供COA,氫譜,質(zhì)譜,液相等

歡迎咨詢訂購!

舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |